Open-label, Randomized, 2-way Crossover, Monocentric, Controlled Study to Evaluate the Effect on Daily PHE Fluctuation of PKU GOLIKE Versus SoC in Patients With PKU.

Phase

TERMINATED

Status

Enrollment

OTHER

Sponsor class

Stopped Due to recruitment challenges, and despite an extension of the study period, the decision to terminate the trial early was made in agreement with the Principal Investigator

Conditions

Phenylketonurias

Interventions

DIETARY_SUPPLEMENT: PKU GOLIKE
DIETARY_SUPPLEMENT: Standard of Care

Sponsor

APR Applied Pharma Research s.a.